argenx SE | Investor Day Presentation Deck | 69 slides · page 40 of 69
The slide depicts a step-by-step biological pathway (1-6) showing how autoantibodies lead to blister formation. It also highlights the therapeutic target Efgartigimod.
Conference presentation · other · illustrate_case · balanced density
Slide locked Sign in to view
Slide schematic 4/4
image 1/1 list 1/1 source-note 1/1 title 1/1
Components 4
infographic bullet source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1